SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Tarangelo James J.

(Last) (First) (Middle)
2400 MARKET STREET

(Street)
PHILADELPHIA PA 19103

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/13/2024
3. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP and CFO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 30,338.42 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (1) 02/07/2024 Common Stock 7,770 18.47 D
Stock Option (Right to Buy) (1) 11/19/2024 Common Stock 8,365 20.67 D
Stock Option (Right to Buy) (1) 11/20/2025 Common Stock 7,909 23.55 D
Stock Option (Right to Buy) (1) 11/18/2026 Common Stock 8,852 24.58 D
Stock Option (Right to Buy) (1) 11/16/2027 Common Stock 6,419 29.38 D
Stock Option (Right to Buy) (1) 11/15/2028 Common Stock 6,719 26.5 D
Stock Option (Right to Buy) (1) 11/21/2029 Common Stock 5,919 30.6 D
Stock Option (Right to Buy) (2) 06/30/2030 Common Stock 25,140 16.28 D
Stock Option (Right to Buy) (1) 09/04/2030 Common Stock 31,027 20.41 D
Stock Option (Right to Buy) (3) 11/18/2031 Common Stock 12,533 26.6 D
Stock Option (Right to Buy) (4) 11/17/2032 Common Stock 9,787 29.06 D
Stock Option (Right to Buy) (5) 11/27/2033 Common Stock 10,012 28.05 D
Explanation of Responses:
1. Represents stock options, all of which are fully vested.
2. Represents stock options, 18,854 of which have fully vested and 6,286 which will vest on June 30, 2024.
3. Represents stock options, 8,354 of which have fully vested and 4,179 which will vest on November 18, 2024.
4. Represents stock options, 2,446 which have fully vested, 2,446 which will vest on November 17, 2024, 2,446 which will vest on November 17, 2025, and 2,449 which will vest on November 17, 2026.
5. Represents stock options, 2,503 which will vest on November 27, 2024, 2,503 which will vest on November 27, 2025, 2,503 which will vest on November 27, 2026, and 2,503 which will vest on November 27, 2027.
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Harold B. Dichter, as Attorney-in-fact 01/18/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Document

James J. Tarangelo

POWER OF ATTORNEY


The undersigned hereby constitutes and appoints each of Harold B. Dichter, Paige E. Fleming, and Christopher J. Lehmann the true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned’s capacity as a director or executive officer of Aramark (the “Company”), as applicable, (i) Forms 3, 4 or 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder (including any amendments thereto) and (ii) such forms as may be required in connection with any applications for EDGAR access codes, including without limitation the Form ID.

(2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete the execution of any such Form 3, 4, or 5 and the timely filing of such form with the United States Securities and Exchange Commission and any other authority; and

(3) take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in their discretion.

The undersigned hereby grants to such attorneys-in-fact full power and authority to do and perform every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that each such attorney-in-fact, or their substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.


IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on the 17th day of January, 2024.


/s/ James J. Tarangelo
Signature
James J. Tarangelo
Printed Name